Germany · Question · Kleine Anfrage
21/8261
Verordnungsfähige Off-Label-Medikamente gegen ME/CFS
Introduced
29 September 2026
Last action
13 October 2026 · Antwort
Status
Beantwortet
Sponsors
—
Subjects
Healthcare
Source updated
20 October 2026
Records
Official question 21/8261 from Germany at German Bundestag. Dated 29 September 2026. Status: Beantwortet.
Timeline
29 September 2026
Kleine Anfrage
Verordnungsfähige Off-Label-Medikamente gegen ME/CFS
Source: BT
13 October 2026
Antwort
Verordnungsfähige Off-Label-Medikamente gegen ME/CFS
Source: BT
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
2 official files
21/8566
This file cannot be previewed here. Use View or Download.
Reading translation
Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.
On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.
21/8566
Drucksache · DE · 13 October 2026
21/8261
Drucksache · DE · 29 September 2026
ViewDownloadOpen at official source
Reading translation
Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.
On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.
Sponsors
- Fraktion DIE LINKE · Fraktion DIE LINKE · initiative
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://dip.bundestag.de/vorgang/verordnungsfahige-off-label-medikamente-gegen-me-cfs/339775
- Open data entity: https://search.dip.bundestag.de/api/v1/vorgang/339775
- germany · 339775 · source updated 20 October 2026